These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10573320)

  • 21. Tardive dyskinesia: review of treatments past, present, and future.
    Gupta S; Mosnik D; Black DW; Berry S; Masand PS
    Ann Clin Psychiatry; 1999 Dec; 11(4):257-66. PubMed ID: 10596740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.
    An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Kosten TR; Zhou DF; Yang FD; Zhang XY
    Behav Pharmacol; 2013 Oct; 24(7):610-6. PubMed ID: 23994817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin E in the treatment of tardive dyskinesia.
    Elkashef AM; Ruskin PE; Bacher N; Barrett D
    Am J Psychiatry; 1990 Apr; 147(4):505-6. PubMed ID: 1969247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic Treatment of Tardive Dyskinesia: A Meta-Analysis and Systematic Review.
    Artukoglu BB; Li F; Szejko N; Bloch MH
    J Clin Psychiatry; 2020 May; 81(4):. PubMed ID: 32459404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction.
    Margolese HC; Chouinard G; Kolivakis TT; Beauclair L; Miller R
    Can J Psychiatry; 2005 Aug; 50(9):541-7. PubMed ID: 16262110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin E in the treatment of tardive dyskinesia: a meta-analysis.
    Xu H; Qin H; Chen S; Guan M
    Int Clin Psychopharmacol; 2022 Mar; 37(2):60-66. PubMed ID: 35045531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of vitamin E for treatment of long-term tardive dyskinesia.
    Dabiri LM; Pasta D; Darby JK; Mosbacher D
    Am J Psychiatry; 1994 Jun; 151(6):925-6. PubMed ID: 8185007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonparkinsonism movement disorders in the elderly.
    Chen JJ; Lee KC
    Consult Pharm; 2006 Jan; 21(1):58-71. PubMed ID: 16524353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tardive dyskinesia.
    Soares-Weiser K; Fernandez HH
    Semin Neurol; 2007 Apr; 27(2):159-69. PubMed ID: 17390261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haloperidol-induced neurotoxicity--possible implications for tardive dyskinesia.
    Galili R; Mosberg ; Gil-Ad I; Weizman A; Melamed E; Offen D
    J Neural Transm (Vienna); 2000; 107(4):479-90. PubMed ID: 11215758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses.
    Sajjad SH
    Int Clin Psychopharmacol; 1998 Jul; 13(4):147-55. PubMed ID: 9727725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of effect of vitamin E on serum creatine phosphokinase in patients with long-term tardive dyskinesia.
    Dorevitch A; Lerner V; Shalfman M; Kalian M
    Int Clin Psychopharmacol; 1997 May; 12(3):171-3. PubMed ID: 9248874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin E treatment of tardive dyskinesia.
    Corrigan FM; Van Rhijn AG; Mackay AV; Skinner ER; Horrobin DF
    Am J Psychiatry; 1993 Jun; 150(6):991-2; author reply 992-3. PubMed ID: 8494096
    [No Abstract]   [Full Text] [Related]  

  • 35. Vitamin E treatment of tardive dyskinesia.
    Holmes VF; D'Alli R; Schweickert L; White R; Brown T; Doraiswamy M; Garcia M
    Am J Psychiatry; 1993 Jun; 150(6):991; author reply 992-3. PubMed ID: 8494095
    [No Abstract]   [Full Text] [Related]  

  • 36. Alpha-tocopherol in tardive dyskinesia.
    Lohr JB; Cadet JL; Lohr MA; Jeste DV; Wyatt RJ
    Lancet; 1987 Apr; 1(8538):913-4. PubMed ID: 2882306
    [No Abstract]   [Full Text] [Related]  

  • 37. Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.
    Cadet JL; Lohr JB
    Ann N Y Acad Sci; 1989; 570():176-85. PubMed ID: 2576510
    [No Abstract]   [Full Text] [Related]  

  • 38. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
    Lerner V; Kaptsan A; Miodownik C; Kotler M
    Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin E in tardive dyskinesia.
    Schneiderhan ME
    Ann Pharmacother; 1993 Mar; 27(3):311-3. PubMed ID: 8453169
    [No Abstract]   [Full Text] [Related]  

  • 40. The treatment of tardive dyskinesia and tardive dystonia.
    Simpson GM
    J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.